procyanidin b2 has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mei, B; Sun, Q; Xiao, Q; Zhang, T; Zhang, X | 1 |
| Chen, J; Chen, K; Dai, W; Fan, X; Feng, J; Guo, C; Ji, J; Li, J; Li, S; Liu, T; Mao, Y; Wang, C; Wang, F; Wu, J; Wu, L; Yu, Q; Zhang, J; Zhou, Y | 1 |
2 other study(ies) available for procyanidin b2 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway.
Topics: Biflavonoids; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Mouth Neoplasms; Neovascularization, Pathologic; Proanthocyanidins; Squamous Cell Carcinoma of Head and Neck; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2022 |
Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis.
Topics: Animals; Biflavonoids; Carbon Tetrachloride; Catechin; Cell Line; Cell Proliferation; Down-Regulation; Hedgehog Proteins; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Morphogenesis; Neovascularization, Pathologic; Proanthocyanidins; Signal Transduction; Transforming Growth Factor beta1; Veratrum Alkaloids | 2019 |